Leukaemia Foundation
Services offered
The main treatment for chronic myeloid leukaemia (CML) uses targeted therapy drugs called tyrosine kinase inhibitors (TKIs). TKIs block the protein tyrosine kinase, stopping the leukaemia from growing and multiplying.
Common side effects of TKIs include fatigue, nausea and diarrhoea. Tell your treatment team about any new or worsening side effects.
Some people also have chemotherapy, usually as a tablet. Immunotherapy is used when people can’t have TKIs.
The main treatment for CML is a group of targeted therapy drugs called tyrosine kinase inhibitors (TKIs). These drugs work by blocking a protein called tyrosine kinase. Tyrosine kinase tells the leukaemia cells to divide and grow. Without this signal, the cells die. Each TKI works in a slightly different way. This means that if one TKI doesn’t control the CML or stops working for you, your doctor may increase the dose or switch you to another type of TKI.
You usually have TKIs as the first treatment, whether CML is in the chronic, accelerated or blast phase. The type of TKI you are prescribed will depend on several factors, including what other medical problems you have. In Australia, TKIs used for CML include imatinib, dasatinib, nilotinib and ponatinib. They are taken as tablets once or twice a day.
A new generation TKI, asciminib, is available for people with CML who cannot tolerate or have developed resistance to older TKIs.
When I was first diagnosed I was put on imatinib, but had severe side effects so my doctor put me on dasatinib. I’ve been on this for over 8 years with excellent results. As the leukaemia is still detected in blood tests, there’s no plan to discontinue treatment in the foreseeable future.
The side effects of TKIs vary depending on the drug and how your body responds. Most side effects are mild and can be treated.
Common side effects may include:
In rare cases, TKIs can affect how the heart works, which can be life-threatening.
Tell your treatment team if you have any of these side effects and let them know if you have a history of heart disease. The team will monitor how you respond to the TKI and explain what side effects to watch out for or report, and who to contact after hours. For information about specific TKIs and their side effects, visit the eviQ cancer treatment website.
Your doctor may be able to prescribe medicine to prevent or reduce side effects. Sometimes your doctor may have to change the dose of the TKI or give you a different TKI.
TKIs can cause the signs and symptoms of CML to reduce or disappear. Most people are able to return to their usual activities. The drugs will need to be taken throughout your life, and you will need to have regular blood tests to check CML hasn’t returned (see Follow-up appointments).
Some people who have had an excellent response to a TKI for at least three years may be able to stop taking these drugs. If you are able to stop, you’ll need frequent check-ups. Half the people who stop have no further issues, and the other half have a relapse and need to start taking TKIs again.
Many TKIs, such as imatinib, are not safe to use during pregnancy or while breastfeeding. Ask your doctor for advice about contraception. If you become pregnant, let your medical team know immediately.
Chemotherapy uses anti-cancer drugs called cytotoxics that kill or slow the growth of the leukaemia cells.
For CML, chemotherapy is used:
The side effects depend on the type of chemotherapy drugs you have. Hydroxyurea tablets may cause dry skin, nausea, drowsiness and a small amount of hair loss. These side effects tend to be mild, and there are medicines available to help manage them. Intravenous chemotherapy uses stronger drugs and usually has more side effects, such as an increased risk of infections, bruising easily, nausea, taste and smell changes, or fatigue.
To find out more about chemotherapy for CML, talk to your medical team, call Cancer Connect on 13 11 20, or contact the Leukaemia Foundation on 1800 620 420.
Immunotherapy aims to change how your immune system responds to the leukaemia. The immunotherapy drug interferon alfa was the main treatment for CML before TKIs were developed. Although this drug is not used very often now, it’s being used in some clinical trials to see whether people can stop their TKIs. Interferon alfa is also used in people who are pregnant and can’t have TKIs.
Leukaemia Foundation
Services offered
Find the right services for your needs, wherever you are in Australia
Trusted cancer information for all people affected by cancer
We're available 9am - 5pm, Monday to Friday (excluding public holidays)